Concepedia

Publication | Open Access

Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial

47

Citations

28

References

2022

Year

Abstract

ChiCTR1800015030.

References

YearCitations

Page 1